Back to Search Start Over

Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring.

Authors :
González-Mariño I
Baz-Lomba JA
Alygizakis NA
Andrés-Costa MJ
Bade R
Bannwarth A
Barron LP
Been F
Benaglia L
Berset JD
Bijlsma L
Bodík I
Brenner A
Brock AL
Burgard DA
Castrignanò E
Celma A
Christophoridis CE
Covaci A
Delémont O
de Voogt P
Devault DA
Dias MJ
Emke E
Esseiva P
Fatta-Kassinos D
Fedorova G
Fytianos K
Gerber C
Grabic R
Gracia-Lor E
Grüner S
Gunnar T
Hapeshi E
Heath E
Helm B
Hernández F
Kankaanpaa A
Karolak S
Kasprzyk-Hordern B
Krizman-Matasic I
Lai FY
Lechowicz W
Lopes A
López de Alda M
López-García E
Löve ASC
Mastroianni N
McEneff GL
Montes R
Munro K
Nefau T
Oberacher H
O'Brien JW
Oertel R
Olafsdottir K
Picó Y
Plósz BG
Polesel F
Postigo C
Quintana JB
Ramin P
Reid MJ
Rice J
Rodil R
Salgueiro-González N
Schubert S
Senta I
Simões SM
Sremacki MM
Styszko K
Terzic S
Thomaidis NS
Thomas KV
Tscharke BJ
Udrisard R
van Nuijs ALN
Yargeau V
Zuccato E
Castiglioni S
Ort C
Source :
Addiction (Abingdon, England) [Addiction] 2020 Jan; Vol. 115 (1), pp. 109-120. Date of Electronic Publication: 2019 Oct 23.
Publication Year :
2020

Abstract

Background and Aims: Wastewater-based epidemiology is an additional indicator of drug use that is gaining reliability to complement the current established panel of indicators. The aims of this study were to: (i) assess spatial and temporal trends of population-normalized mass loads of benzoylecgonine, amphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in raw wastewater over 7 years (2011-17); (ii) address overall drug use by estimating the average number of combined doses consumed per day in each city; and (iii) compare these with existing prevalence and seizure data.<br />Design: Analysis of daily raw wastewater composite samples collected over 1 week per year from 2011 to 2017.<br />Setting and Participants: Catchment areas of 143 wastewater treatment plants in 120 cities in 37 countries.<br />Measurements: Parent substances (amphetamine, methamphetamine and MDMA) and the metabolites of cocaine (benzoylecgonine) and of Δ <superscript>9</superscript> -tetrahydrocannabinol (11-nor-9-carboxy-Δ <superscript>9</superscript> -tetrahydrocannabinol) were measured in wastewater using liquid chromatography-tandem mass spectrometry. Daily mass loads (mg/day) were normalized to catchment population (mg/1000 people/day) and converted to the number of combined doses consumed per day. Spatial differences were assessed world-wide, and temporal trends were discerned at European level by comparing 2011-13 drug loads versus 2014-17 loads.<br />Findings: Benzoylecgonine was the stimulant metabolite detected at higher loads in southern and western Europe, and amphetamine, MDMA and methamphetamine in East and North-Central Europe. In other continents, methamphetamine showed the highest levels in the United States and Australia and benzoylecgonine in South America. During the reporting period, benzoylecgonine loads increased in general across Europe, amphetamine and methamphetamine levels fluctuated and MDMA underwent an intermittent upsurge.<br />Conclusions: The analysis of wastewater to quantify drug loads provides near real-time drug use estimates that globally correspond to prevalence and seizure data.<br /> (© 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.)

Details

Language :
English
ISSN :
1360-0443
Volume :
115
Issue :
1
Database :
MEDLINE
Journal :
Addiction (Abingdon, England)
Publication Type :
Academic Journal
Accession number :
31642141
Full Text :
https://doi.org/10.1111/add.14767